ICI-170777
ICI-170777 is an orally active cardiotonic agent. ICI-170777 enhances cardiac contractility and induces arteriovenous dilation in animal models of congestive heart failure. ICI-170777 can be used in research on cardiovascular and cerebrovascular diseases such as heart failure[1].
Product Specifications
CAS Number
123297-52-9
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Others
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
O=C1SC(C)C(C2=CC=NC=C2)=NN1
Molecular Formula
C9H9N3OS
Molecular Weight
207.25
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Collis MG, et al. The cardiovascular pharmacology of ICI 170777 ((6RS) -6-methyl-5- (pyrid-4-yl) -3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects. Br J Pharmacol. 1989 Jun;97 (2) :409-18.
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1165008 1.0 µg DNA
KRR1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details